Clinical Research Directory
Browse clinical research sites, groups, and studies.
The Safety/Efficacy of hUC Mesenchymal Stem Cells(19#iSCLife®-OA) Therapy for Patients With Osteoarthritis
Sponsor: Sclnow Biotechnology Co., Ltd.
Summary
The purpose of this study is verify the efficacy and safety of Human Umbilical Cord Mesenchymal Stem Cells (UC-MSC) therapy for patients with Osteoarthritis, and in addition, provide basis for exploring the treatment regimen of UC-MSC therapy in different degree of cartilage defect disease
Official title: A Clinical Research on the Safety/Efficacy of Human Umbilical Cord Mesenchymal Stem Cells(19#iSCLife®-OA) Therapy for Patients With Osteoarthritis
Key Details
Gender
All
Age Range
Any - 70 Years
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2018-10-01
Completion Date
2026-12-31
Last Updated
2025-12-04
Healthy Volunteers
No
Conditions
Interventions
Low dose mesenchymal stem cells
Human umbilical cord mesenchymal stem cells (SCLnow 19#): group A, 1 \* 10\^7 cells (5ml);
High dose mesenchymal stem cells
Human umbilical cord mesenchymal stem cells (SCLnow 19#): group B, 2 \* 10\^7 cells (5ml)
Intraarticular injection
Intraarticular injection with human umbilical cord mesenchymal stem cells (SCLnow 19#) with different dose group
Locations (1)
Xiangya Hospital Central South University
Changsha, Hunan, China